Aneurysmal Subarachnoid Hemorrhage: the Last Decade

Area of Science:

• Neurology
• Neurosurgery
• Critical Care Medicine

Background:

• Aneurysmal subarachnoid hemorrhage (SAH) has a high mortality rate (35%) and causes significant long-term disability, particularly cognitive dysfunction.
• While diagnosis is improving with advanced CT scans and clinical decision rules, a high index of suspicion remains crucial for physicians.
• Current management relies on limited randomized clinical trials (RCTs), highlighting a need for more evidence-based practices.

Purpose of the Study:

• To review the current management strategies for aneurysmal subarachnoid hemorrhage (SAH).
• To emphasize the importance of early aneurysm repair and specialized neurological intensive care.
• To identify areas requiring further research, particularly concerning complications like delayed cerebral ischemia (DCI).

Main Methods:

• Review of existing literature and clinical guidelines for SAH management.
• Analysis of prognostic factors influencing patient outcomes post-SAH.
• Discussion of medical management strategies focusing on minimizing early brain injury and preventing DCI.

Main Results:

• Endovascular coiling is generally superior to neurosurgical clipping for aneurysm repair when both are feasible.
• Early brain injury and delayed cerebral ischemia (DCI) are the primary determinants of patient outcome.
• Management in specialized neurological ICUs by multidisciplinary teams is associated with better outcomes.
• Nimodipine is the only approved pharmacologic treatment, underscoring the lack of other proven interventions.

Conclusions:

• Early aneurysm repair is critical to prevent rebleeding.
• Minimizing early brain injury and proactively managing DCI are key to improving SAH patient outcomes.
• Further research into SAH complications, especially DCI, is essential to optimize care for this vulnerable patient population.